{"name":"David Wilson","slug":"david-wilson","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNeVhhcmNuX3psOXhUUjBkaWxIMHhxVGNWdEx5WmJBNWVRb3M3enJlMmd1U3cwR2tfdUVWTFBET3VoX3RQOWVMREt1MWdfNzVPby11cVhiU0J1TmdINmN6Z242OXFzWDBQSmEtUFlsTTFZSGhRSlF1TjM5Y0xSWmw3ZVFkRGNidTRad1RJNkZmU0RkUkJ1ZUo1cWFhOGRKN2VUVnhfRHdIS1RDUWFmRHJMcXJEWkJ0Sm9zRVE?oc=5","date":"2026-02-11","type":"pipeline","source":"The Washington Post","summary":"Big Pharma dodges bullet in affordability hearing - The Washington Post","headline":"Big Pharma dodges bullet in affordability hearing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPbE5Uc0hBanN6Wk9ubEExaEhrcHRUeEN2cno0MUM2Y0V0UFJzMWhhYXE5YWxua1o3NWFud0F3bjlqT3hoY1ZvSlI0elpJMmlJTXdfUkliRE9nN0ZGcVN6WmtCNjZZR0JvOXo1cDBpeTQzNnB1QXNYREVoeG1zNHpFZnBtWlpaYUE3WmRWU3RGS2VoZGdHVC1VWWdMUFZoajJVWjUtcWtR?oc=5","date":"2026-01-23","type":"pipeline","source":"The Washington Post","summary":"Pharma poised for big win over PBMs - The Washington Post","headline":"Pharma poised for big win over PBMs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOQUR1MGZ1Y1FLYlBiRGlmLXZLT2I5Q0FLNmZ6amxtR0YzcVhqbnh0am5CYXhHQ2J3Q3lmTk5QUkVNc0RmMU54bi1zaF9zSnNkWmU0eHh2TnVFWE9LYnlSa1ZYT054QTZfZzV5eXpoTUJHY0pNbGJSZ2JwazZ6V093VmFvTl9NNmtJUllmTjlJcw?oc=5","date":"2025-10-10","type":"pipeline","source":"Fierce Biotech","summary":"AstraZeneca: Building a transparent pipeline from the ground up - Fierce Biotech","headline":"AstraZeneca: Building a transparent pipeline from the ground up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOV1VqUDlsMmp0c0hXenpTTzNUZ25ZRWM2Mi1neXdhY2dVQUlONEVfbmZoa0o4ODFJZTBxUGtVeUFiY00tUGZIajFLY2hUZFNQeS1UOFlOTnBfTzcwbzNYQm5kRXdpaU9ZeFQ4R3JMZVYwazlsZGJxSXRWN2w4cFE0YlVNZ0hWMElJNFNj?oc=5","date":"2025-08-30","type":"pipeline","source":"The Lancet","summary":"David Wilson - The Lancet","headline":"David Wilson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTFBjVVRDSzItUmt2Vlo5UzVhSmhXTlprWDN4V2NJUGk3U1VPbUZKaF9FOGFiNEhYN0JqM3lUVkM3Q3NZbnNvblBlUVpTUmFPNUIzWGZqMDVDTDhnSU0?oc=5","date":"2025-07-13","type":"pipeline","source":"Orleans Hub","summary":"David J. Wilson - Orleans Hub","headline":"David J. Wilson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNDJqdnpLWnFEWU1SdXRhV0Q4bGNFOXNzdzFJclFpS0xKSFBjZ01fUTVJWm52YTl5S3RFSTlSWm9vTGR1ZjdpVUc4WlRhUV9TRG9va0FyMGhYNmpoSmhSUzBzdy1sb01uSUZ0Q1AwWWtUS2NzdkYyVWZCZjV1TFE3N1EyeUhwX1dZVjVuSy0xb0NyUFNnTl9sakt4LXQ4dw?oc=5","date":"2025-07-08","type":"pipeline","source":"worcesternews.co.uk","summary":"Worcestershire specialist to lead research into rare heart condition - worcesternews.co.uk","headline":"Worcestershire specialist to lead research into rare heart condition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOWlFiM3VUYm81X09VRFhOMk1sRUxydHdvaVp0alViQUdETkJHZkk2LUNPX3E0bHdYb2c2ZmdhU2tUdXBUcENjZDFoMmZaVEZKOGh1bXJOUWpQeFltb0MtN083U3hCUVdfV1lHM3ZjS0tVT3lCVnFWc09RaWFwMTJGdnBfYXR2eGRvQ0NlOU15V01rSmM?oc=5","date":"2025-06-02","type":"pipeline","source":"Blueprint Magazine","summary":"Sheila Mason-Henry – Otsuka America Pharmaceutical Inc. - Blueprint Magazine","headline":"Sheila Mason-Henry – Otsuka America Pharmaceutical Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOWThTdDd1amtNemd6TlRCNGo1cHV0ZGphUmViV1NBYkFZaFVaN3VteFFPY1pOWHlRamJEczZEZG5heE4wblRpY2tGNlhmVUN5MWxnSEhfNks1UVMza2RsLWQyQ2tnVllnU2NUQXkzS3RCc1U1cnFDTHVqS01MRDA4Y0plQWhYb3NyWEVrRXhRTHBSR0RwTkdoZUdwNC1VR0JBUjlUbWFNUXlPN3RFT3o2MV9HNVNHdWIyM0dwQ0VLaFFTMTFm?oc=5","date":"2025-01-28","type":"pipeline","source":"wsgr.com","summary":"Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing - wsgr.com","headline":"Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNdk1GM2sybzIxMG9SUzVTY19UNEc5c25PU0gzR2twbGlvMzVrSU5TVnNFdEE3NGN6LW01QjdLZVFyTGpTUVF5dXRham8yNklBN3lib2xNTDRJOG5CREhyQ1J3VzJDS3B5Ql8xdUhNQ0RoV2ItNnN3OVZiYkFrdnYzRFVR?oc=5","date":"2022-06-16","type":"pipeline","source":"campdenfb.com","summary":"David G. Wilson: Breaking the third-generation curse - campdenfb.com","headline":"David G. Wilson: Breaking the third-generation curse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE44NUdUMHhPaEQ1QUNLT3dIT2FQUmJ5MDA2YlE3THNXVTBVZE9sVVpTaWpWVUNneWNYU0ozcE10UmxYdlpoeE5Fb0J5ZTdFelVNR2huTXBOcnpZNkg4N2xTeUVaczNNVm43SHYyNGJ3?oc=5","date":"2022-02-28","type":"pipeline","source":"technical.ly","summary":"Technical.ly DC Diaries: David Wilson, founder and principal at Franklin Advisory - technical.ly","headline":"Technical.ly DC Diaries: David Wilson, founder and principal at Franklin Advisory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVEVWYnJLZzhuZ2tMY1J1NkF0Ymx5NWYzSWptNlphVC1jU1FUNWc1dW53aVBERjRNRHlzZ1J4TktwR3JyY3ExUkdrb3JocFpfUDNfMkxQdGVIazNmcVBXSDVDeTdDRnRrUmQyNUJ0ZU5WQU5sMFRWa1pSQlBWZXIwS3pXRWFLUWJrRFhHRGtja2R5UDjSAZgBQVVfeXFMTXpsSUJWdTBpbXoxcElreWptclduNmt3ZEowSm5iaVhFRFRZaUlCenJudld3ajhXYU1vM2lKZEJROGx5M2xiWElGRWZfS2lfMTVVZGcwV3dJRzNOcjNLVDlIVGZZbGVhbExUNDFzVkp3RWRwMkdLVGtYT3BuWkd6Rjd1c3RiWnBBMEtmTS1SZUxZUWp5U1lIbHM?oc=5","date":"2021-09-23","type":"pipeline","source":"wavy.com","summary":"Candidate Profile: David Wilson (District 95) - wavy.com","headline":"Candidate Profile: David Wilson (District 95)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1rVlRTSGV2VzVVdGNHbGlUOG1GLXQ1b1htTTdwRzZvYmh3NFhjLVI5UGxMLVJhamdYR3c3OWVkZ2JBSHhkZVQ5NTItc1ZqXzgzVGV6dmdRX2RjeG5PTVZONGhuU1lfa0dOWG9Md0xpNFpqYWllVzJQYXhzcFQ?oc=5","date":"2021-08-24","type":"pipeline","source":"Blueprint Magazine","summary":"David Wilson – Avanir Pharmaceuticals - Blueprint Magazine","headline":"David Wilson – Avanir Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}